Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients
Anna P. Sokolenko, Tatiana V. Gorodnova, Ilya V. Bizin, Ekatherina Sh. Kuligina, Khristina B. Kotiv, Alexandr A. Romanko, Tatiana I. Ermachenkova, Alexandr O. Ivantsov, Elena V. Preobrazhenskaya, Tatiana N. Sokolova, Robert V. Broyde, Evgeny N. Imyanitov
Topics & Concepts
CarboplatinSerous ovarian cancerPaclitaxelMedicineOncologyOvarian cancerInternal medicineSerous fluidNeoadjuvant therapyChemotherapyCancerCisplatinBreast cancerOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyCancer Genomics and Diagnostics